CFTR and cystic fibrosis: In order to do this, we designed a sub-study as part of an ongoing prospective longitudinal observational study at our CF center and measured the CFTR biomarkers sweat chloride concentration and ICM as well as clinical outcomes like BMI, spirometry and LCI at baseline and 8–16 weeks after starting treatment with LUM/IVA.